Table 1.
Characteristic | Total (N = 142) | Usual Care (N = 68) | MBSR(BC) (N = 74) | p value |
---|---|---|---|---|
Mean age (SD), years | 55.31 (9.84) | 55.19 (9.15) | 55.42 (10.49) | .89 |
Mean days since the end of adjuvant treatment (SD) | 238 (224) | 212 (258) | 261 (187) | .20 |
Race/ethnicity, n (%) | .71 | |||
White, non-Hispanic | 101 (71.1) | 49 (72.1) | 52 (70.3) | .55 |
White, Hispanic | 15 (10.6) | 7 (10.3) | 8 (10.8) | .47 |
Black, non-Hispanic | 17 (12.0) | 10 (14.7) | 7 (9.5) | .24 |
Other | 9 (5.6) | 2 (3.0) | 7 (9.5) | .13 |
Educational status, n (%)a | .87 | |||
High school or less | 24 (17.0) | 12 (17.9) | 12 (16.2) | |
Some college | 57 (40.4) | 28 (41.8) | 29 (39.2) | |
College or professional degrees | 60 (42.6) | 27 (40.3) | 33 (44.6) | |
Employment status, n (%)a | .07 | |||
Employed | 60 (42.6) | 34 (50.7) | 26 (35.1) | |
Retired | 31 (22.0) | 11 (16.4) | 20 (27.0) | |
Disabled/medical leave | 13 (9.2) | 4 (6.0) | 9 (12.2) | |
Unemployed | 17 (12.1) | 11 (16.4) | 6 (8.1) | |
Other | 20 (14.2) | 7 (10.4) | 13 (17.6) | |
Breast cancer stage, n (%) | .41 | |||
Stage 0 | 14 (9.9) | 8 (11.8) | 6 (8.1) | |
Stage I | 57 (40.1) | 31 (45.6) | 26 (35.1) | |
Stage II | 54 (38.0) | 22 (32.4) | 32 (43.2) | |
Stage III | 17 (12.0) | 7 (10.3) | 10 (13.5) | |
Adjuvant treatment type, n (%) | .57 | |||
Chemotherapy | 24 (16.9) | 14 (20.6) | 10 (13.5) | |
Radiation | 35 (24.6) | 17 (25.0) | 18 (24.3) | |
Chemotherapy and radiation | 51 (35.9) | 21 (30.9) | 30 (40.5) | |
None | 32 (22.5) | 16 (23.5) | 16 (21.6) | |
Surgery type, n (%) | .87 | |||
Lumpectomy | 60 (42.3) | 28 (41.2) | 32 (43.2) | |
Mastectomy | 82 (57.7) | 40 (58.8) | 42 (56.8) | |
Comorbidities, n (%) | .37 | |||
Diabetes | 15 (14.4) | 8 (15.7) | 7 (13.2) | |
Cardiovascular problems | 9 (6.3) | 3 (4.4) | 6 (8.1) |
Note. MBSR(BC) = mindfulness-based stress reduction intervention for breast cancer survivors.
One usual care participant did not respond to the questions on education or employment.